International Journal of Molecular Sciences, 2018 · DOI: 10.3390/ijms19061701 · Published: June 7, 2018
Spinal cord injuries (SCI) often lead to impaired neuromuscular function and reduced musculoskeletal health, hindering recovery. Activity-based therapies (ABTs) aim to promote neuromuscular plasticity but are limited by SCI severity. Many men with SCI also experience low testosterone, potentially worsening these impairments. Adding testosterone to ABTs may enhance musculoskeletal recovery and neuroplasticity. Testosterone can help prevent muscle loss and promote motoneuron survival after SCI. While testosterone alone may not provide significant functional improvements, combining it with ABTs like bodyweight-supported treadmill training (BWSTT) could lead to more comprehensive recovery. This review explores the molecular reasons for muscle loss after SCI, the separate effects of testosterone and locomotor training, how these strategies work, and the potential of combining ABT with testosterone for better recovery.
Combining testosterone therapy with activity-based rehabilitation may offer enhanced recovery outcomes for individuals with SCI.
Understanding the molecular mechanisms underlying the benefits of testosterone and ABTs can lead to more targeted therapeutic interventions.
Assessing testosterone levels in men with SCI and tailoring treatment plans to address hormonal deficiencies may improve rehabilitation outcomes.